
Contact & links
2301 Avenue d’Estimauville Québec (Québec) G1E 0N5 Canada
Gabriel Bossé
PhD
Assistant Professor, Département de psychiatrie et de neurosciences, Faculté de médecine
Université Laval
Research axis:
Integrative Neuroscience and Experimental Therapies
Zebrafish is an unique model in neuroscience; key neurological pathways are well conserved and we can used genetics and pharmacological tools to investigate brain functions. This model is also suitable for large-scale approaches and drug discovery efforts. We are using a range of techniques from behavioural platforms, imaging, genetic tools (transgenic lines, CRISPR-Cas9) and pharmacological tools. Our main research interest are:
Neurobiology of opioid addiction
We are using a unique opioid self-administration assay to study the molecular pathways involved in drug seeking behaviour.
Impact of neurosteroids on behaviour
Using large scale approaches we are interested in studying the neurological impact of unique neurosteroids.
Long-term consequences of neonatal opioid exposure
We are generating a new zebrafish model to study the behavioural and molecular impact of embryonic opioid exposure
Our group is using zebrafish to study the biological mechanisms involved in controlling behaviour, focusing on opioid addiction.
Using a novel self-administration assay, we are studying the role of neurosteroids in opioid intake and using a combination of pharmacology, genetics, and imaging methods to identify novel biological pathways involves in drug addiction.
We are also developing a new model to study the biological and behavioural consequences of neonatal opioid exposure in zebrafish.
Our behaviour-based platform is also used to perform small molecule screening to identify novel neuroactive molecules. The compounds uncovered and their cellular targets have the potential to uncover novel pathways and therapeutic approaches, as I have already shown with finasteride.
Publications
Léa Morneau; Léa Gagné; Randall T Peterson; Gabriel D Bossé
A novel single-fish assay for ethanol self-administration in zebrafish Journal Article
In: Prog Neuropsychopharmacol Biol Psychiatry, vol. 150, pp. 111967, 2026, ISSN: 1878-4216.
@article{pmid42838214,
title = {A novel single-fish assay for ethanol self-administration in zebrafish},
author = {Léa Morneau and Léa Gagné and Randall T Peterson and Gabriel D Bossé},
doi = {10.1016/j.pnpbp.2026.111967},
issn = {1878-4216},
year = {2026},
date = {2026-10-01},
journal = {Prog Neuropsychopharmacol Biol Psychiatry},
volume = {150},
pages = {111967},
abstract = {Alcohol use disorder (AUD) is a significant public health concern. In Canada, about 18% of individuals aged 15 or older will meet the clinical criteria for AUD at some point in their lives (CAMH, 2023). Treatment options for AUD are limited, and the high relapse rates highlight the urgent need for innovative methods to study and address AUD. Zebrafish (Danio rerio) is an emerging model for exploring the neurobiological impacts of alcohol. Previous studies have demonstrated that zebrafish respond to the rewarding effects of alcohol, but most research methods rely on passive administration, such as immersion, which does not reflect the typical routes of alcohol intake in humans. We previously showed that zebrafish can learn to self-administer drugs of abuse in small groups and conditioned animals are displaying key features of substance abuse disorders. However, group-based conditioning limits our understanding of individual drug preference and intake profile. In this study, we improved upon our previous design by establishing an individual self-administration protocol to measure voluntary alcohol intake and model alcohol use disorder. In this novel assay, individual adult fish learn to discriminate between two zones to self-administer a 5% ethanol solution. Moreover, animals conditioned in this assay can perform progressive ratio and display signs of withdrawal upon cessation of ethanol intake. These results suggest zebrafish can develop ethanol abuse-like behaviour, providing a powerful platform to study genetic predisposition and screen for therapeutic compounds.},
keywords = {},
pubstate = {published},
tppubtype = {article}
}
Lise Hermant; Gabriel D Bossé
Prenatal polysubstance exposure alters behaviour in zebrafish larvae Journal Article
In: Prog Neuropsychopharmacol Biol Psychiatry, vol. 146, pp. 111686, 2026, ISSN: 1878-4216.
@article{pmid41905434,
title = {Prenatal polysubstance exposure alters behaviour in zebrafish larvae},
author = {Lise Hermant and Gabriel D Bossé},
doi = {10.1016/j.pnpbp.2026.111686},
issn = {1878-4216},
year = {2026},
date = {2026-04-01},
journal = {Prog Neuropsychopharmacol Biol Psychiatry},
volume = {146},
pages = {111686},
abstract = {Substance use during pregnancy has been linked to various adverse outcomes in infants, including congenital disabilities, neurodevelopmental delays, and long-term effects such as learning difficulties. An additional concern is that newborns are often exposed to multiple substances in utero. The biological consequences of such exposure remain largely unknown. Zebrafish offer an exciting alternative to fill this gap and deepen our understanding of the biological impact of prenatal multidrug exposure. We utilized zebrafish's scalability to expose embryos to some of the most commonly used substances: nicotine, alcohol, opioids, and all their possible combinations. After embryonic drug exposure, we conducted a detailed behavioural analysis across three developmental stages. Our results revealed drug-specific outcomes, including both synergistic and antagonistic effects. Furthermore, we identified distinctive effects across development, highlighting potential developmental shifts and individual differences in resilience. Overall, these findings demonstrate that prenatal polydrug exposure results in complex, stage-dependent effects, sometimes antagonistic, which cannot be predicted from single-drug outcomes. Our study emphasizes the value of zebrafish as a model for investigating polydrug interactions and provides a framework for exploring biomarkers of vulnerability and resilience in offspring.},
keywords = {},
pubstate = {published},
tppubtype = {article}
}
Margaux Caperaa; Mathilde Roland-Caverivière; Chelsea Herdman; Nesrine Imloul; Sandrine Poulin; Mado Lemieux; Paul De Koninck; Gabriel D Bossé
Development of sensorimotor responses in larval zebrafish: A comparison between wild-type and GCaMP6s transgenic line Journal Article
In: Behav Brain Res, vol. 481, pp. 115412, 2025, ISSN: 1872-7549.
@article{pmid39746401,
title = {Development of sensorimotor responses in larval zebrafish: A comparison between wild-type and GCaMP6s transgenic line},
author = {Margaux Caperaa and Mathilde Roland-Caverivière and Chelsea Herdman and Nesrine Imloul and Sandrine Poulin and Mado Lemieux and Paul De Koninck and Gabriel D Bossé},
doi = {10.1016/j.bbr.2024.115412},
issn = {1872-7549},
year = {2025},
date = {2025-03-01},
journal = {Behav Brain Res},
volume = {481},
pages = {115412},
abstract = {During early development, zebrafish larvae exhibit stereotypical behaviors, which rapidly become more complex. Thus, generating mutant transgenic lines that maintain transparency throughout their larval stage and that can be used to record brain activity has offered strategic opportunities to investigate the underlying neural correlates of behavior establishment. However, few studies have documented the sensorimotor profile of these lines during larval development. Here, we set up a behavioral characterization using diverse stimuli (light and vibration) throughout larval development to compare the responses of a transgenic strain expressing a pan-neuronal calcium indicator (GCaMP6s) with that of a wild-type strain. Interestingly, we report a drastic switch in behavioral responses to light transitions at 11 days post-fertilization (dpf) and to vibration stimuli at 14 dpf in both lines. These data highlight a specific time window representing an increase in behavioral complexity. Meanwhile, we found some differences in the maturation of sensorimotor responses between GCaMP6s and wild-type strains. Although some of these differences are minor, they highlight the need for careful attention when using mutant/transgenic lines for behavioral studies. Overall, our results support using GCaMP6s strain in investigating the neural mechanisms underlying the developmental maturation of sensorimotor responses.},
keywords = {},
pubstate = {published},
tppubtype = {article}
}
Stephanie A Carmack; Janaina C M Vendruscolo; M Adrienne McGinn; Jorge Miranda-Barrientos; Vez Repunte-Canonigo; Gabriel D Bosse; Daniele Mercatelli; Federico M Giorgi; Yu Fu; Anthony J Hinrich; Francine M Jodelka; Karen Ling; Robert O Messing; Randall T Peterson; Frank Rigo; Scott Edwards; Pietro P Sanna; Marisela Morales; Michelle L Hastings; George F Koob; Leandro F Vendruscolo
Corticosteroid sensitization drives opioid addiction Journal Article
In: Mol Psychiatry, vol. 27, no. 5, pp. 2492–2501, 2022, ISSN: 1476-5578.
@article{pmid35296810,
title = {Corticosteroid sensitization drives opioid addiction},
author = {Stephanie A Carmack and Janaina C M Vendruscolo and M Adrienne McGinn and Jorge Miranda-Barrientos and Vez Repunte-Canonigo and Gabriel D Bosse and Daniele Mercatelli and Federico M Giorgi and Yu Fu and Anthony J Hinrich and Francine M Jodelka and Karen Ling and Robert O Messing and Randall T Peterson and Frank Rigo and Scott Edwards and Pietro P Sanna and Marisela Morales and Michelle L Hastings and George F Koob and Leandro F Vendruscolo},
doi = {10.1038/s41380-022-01501-1},
issn = {1476-5578},
year = {2022},
date = {2022-05-01},
journal = {Mol Psychiatry},
volume = {27},
number = {5},
pages = {2492--2501},
abstract = {The global crisis of opioid overdose fatalities has led to an urgent search to discover the neurobiological mechanisms of opioid use disorder (OUD). A driving force for OUD is the dysphoric and emotionally painful state (hyperkatifeia) that is produced during acute and protracted opioid withdrawal. Here, we explored a mechanistic role for extrahypothalamic stress systems in driving opioid addiction. We found that glucocorticoid receptor (GR) antagonism with mifepristone reduced opioid addiction-like behaviors in rats and zebrafish of both sexes and decreased the firing of corticotropin-releasing factor neurons in the rat amygdala (i.e., a marker of brain stress system activation). In support of the hypothesized role of glucocorticoid transcriptional regulation of extrahypothalamic GRs in addiction-like behavior, an intra-amygdala infusion of an antisense oligonucleotide that blocked GR transcriptional activity reduced addiction-like behaviors. Finally, we identified transcriptional adaptations of GR signaling in the amygdala of humans with OUD. Thus, GRs, their coregulators, and downstream systems may represent viable therapeutic targets to treat the "stress side" of OUD.},
keywords = {},
pubstate = {published},
tppubtype = {article}
}
Gabriel D Bosse; Roberto Cadeddu; Gabriele Floris; Ryan D Farero; Eva Vigato; Suhjung J Lee; Tejia Zhang; Nilesh W Gaikwad; Kristen A Keefe; Paul Em Phillips; Marco Bortolato; Randall T Peterson
The 5α-reductase inhibitor finasteride reduces opioid self-administration in animal models of opioid use disorder Journal Article
In: J Clin Invest, vol. 131, no. 10, 2021, ISSN: 1558-8238.
@article{pmid33848264,
title = {The 5α-reductase inhibitor finasteride reduces opioid self-administration in animal models of opioid use disorder},
author = {Gabriel D Bosse and Roberto Cadeddu and Gabriele Floris and Ryan D Farero and Eva Vigato and Suhjung J Lee and Tejia Zhang and Nilesh W Gaikwad and Kristen A Keefe and Paul Em Phillips and Marco Bortolato and Randall T Peterson},
doi = {10.1172/JCI143990},
issn = {1558-8238},
year = {2021},
date = {2021-05-01},
journal = {J Clin Invest},
volume = {131},
number = {10},
abstract = {Opioid use disorder (OUD) has become a leading cause of death in the United States, yet current therapeutic strategies remain highly inadequate. To identify potential treatments for OUD, we screened a targeted selection of over 100 drugs using a recently developed opioid self-administration assay in zebrafish. This paradigm showed that finasteride, a steroidogenesis inhibitor approved for the treatment of benign prostatic hyperplasia and androgenetic alopecia, reduced self-administration of multiple opioids without affecting locomotion or feeding behavior. These findings were confirmed in rats; furthermore, finasteride reduced the physical signs associated with opioid withdrawal. In rat models of neuropathic pain, finasteride did not alter the antinociceptive effect of opioids and reduced withdrawal-induced hyperalgesia. Steroidomic analyses of the brains of fish treated with finasteride revealed a significant increase in dehydroepiandrosterone sulfate (DHEAS). Treatment with precursors of DHEAS reduced opioid self-administration in zebrafish in a fashion akin to the effects of finasteride. These results highlight the importance of steroidogenic pathways as a rich source of therapeutic targets for OUD and point to the potential of finasteride as a new treatment option for this disorder.},
keywords = {},
pubstate = {published},
tppubtype = {article}
}
Gabriel D Bosse; Cristoval Urcino; Maren Watkins; Paula Flórez Salcedo; Sabrina Kozel; Kevin Chase; April Cabang; Samuel S Espino; Helena Safavi-Hemami; Shrinivasan Raghuraman; Baldomero M Olivera; Randall T Peterson; Joanna Gajewiak
Discovery of a Potent Conorfamide from Using a Novel Zebrafish Larvae Assay Journal Article
In: J Nat Prod, vol. 84, no. 4, pp. 1232–1243, 2021, ISSN: 1520-6025.
@article{pmid33764053,
title = {Discovery of a Potent Conorfamide from Using a Novel Zebrafish Larvae Assay},
author = {Gabriel D Bosse and Cristoval Urcino and Maren Watkins and Paula Flórez Salcedo and Sabrina Kozel and Kevin Chase and April Cabang and Samuel S Espino and Helena Safavi-Hemami and Shrinivasan Raghuraman and Baldomero M Olivera and Randall T Peterson and Joanna Gajewiak},
doi = {10.1021/acs.jnatprod.0c01297},
issn = {1520-6025},
year = {2021},
date = {2021-04-01},
journal = {J Nat Prod},
volume = {84},
number = {4},
pages = {1232--1243},
abstract = {Natural products such as conotoxins have tremendous potential as tools for biomedical research and for the treatment of different human diseases. Conotoxins are peptides present in the venoms of predatory cone snails that have a rich diversity of pharmacological functions. One of the major bottlenecks in natural products research is the rapid identification and evaluation of bioactive molecules. To overcome this limitation, we designed a set of light-induced behavioral assays in zebrafish larvae to screen for bioactive conotoxins. We used this screening approach to test several unique conotoxins derived from different cone snail clades and discovered that a conorfamide from , CNF-Ep1, had the most dramatic alterations in the locomotor behavior of zebrafish larvae. Interestingly, CNF-Ep1 is also bioactive in several mouse assay systems when tested and . Our novel screening platform can thus accelerate the identification of bioactive marine natural products, and the first compound discovered using this assay has intriguing properties that may uncover novel neuronal circuitry.},
keywords = {},
pubstate = {published},
tppubtype = {article}
}
Olivia Weeks; Gabriel D Bossé; Isaac M Oderberg; Sebastian Akle; Yariv Houvras; Paul J Wrighton; Kyle LaBella; Isabelle Iversen; Sahar Tavakoli; Isaac Adatto; Arkadi Schwartz; Daan Kloosterman; Allison Tsomides; Michael E Charness; Randall T Peterson; Matthew L Steinhauser; Pouneh K Fazeli; Wolfram Goessling
Fetal alcohol spectrum disorder predisposes to metabolic abnormalities in adulthood Journal Article
In: J Clin Invest, vol. 130, no. 5, pp. 2252–2269, 2020, ISSN: 1558-8238.
@article{pmid32202514,
title = {Fetal alcohol spectrum disorder predisposes to metabolic abnormalities in adulthood},
author = {Olivia Weeks and Gabriel D Bossé and Isaac M Oderberg and Sebastian Akle and Yariv Houvras and Paul J Wrighton and Kyle LaBella and Isabelle Iversen and Sahar Tavakoli and Isaac Adatto and Arkadi Schwartz and Daan Kloosterman and Allison Tsomides and Michael E Charness and Randall T Peterson and Matthew L Steinhauser and Pouneh K Fazeli and Wolfram Goessling},
doi = {10.1172/JCI132139},
issn = {1558-8238},
year = {2020},
date = {2020-05-01},
journal = {J Clin Invest},
volume = {130},
number = {5},
pages = {2252--2269},
abstract = {Prenatal alcohol exposure (PAE) affects at least 10% of newborns globally and leads to the development of fetal alcohol spectrum disorders (FASDs). Despite its high incidence, there is no consensus on the implications of PAE on metabolic disease risk in adults. Here, we describe a cohort of adults with FASDs that had an increased incidence of metabolic abnormalities, including type 2 diabetes, low HDL, high triglycerides, and female-specific overweight and obesity. Using a zebrafish model for PAE, we performed population studies to elucidate the metabolic disease seen in the clinical cohort. Embryonic alcohol exposure (EAE) in male zebrafish increased the propensity for diet-induced obesity and fasting hyperglycemia in adulthood. We identified several consequences of EAE that may contribute to these phenotypes, including a reduction in adult locomotor activity, alterations in visceral adipose tissue and hepatic development, and persistent diet-responsive transcriptional changes. Taken together, our findings define metabolic vulnerabilities due to EAE and provide evidence that behavioral changes and primary organ dysfunction contribute to resultant metabolic abnormalities.},
keywords = {},
pubstate = {published},
tppubtype = {article}
}
Gabriel D Bossé; Randall T Peterson
Development of an opioid self-administration assay to study drug seeking in zebrafish Journal Article
In: Behav Brain Res, vol. 335, pp. 158–166, 2017, ISSN: 1872-7549.
@article{pmid28811180,
title = {Development of an opioid self-administration assay to study drug seeking in zebrafish},
author = {Gabriel D Bossé and Randall T Peterson},
doi = {10.1016/j.bbr.2017.08.001},
issn = {1872-7549},
year = {2017},
date = {2017-09-01},
journal = {Behav Brain Res},
volume = {335},
pages = {158--166},
abstract = {The zebrafish (Danio rerio) has become an excellent tool to study mental health disorders, due to its physiological and genetic similarity to humans, ease of genetic manipulation, and feasibility of small molecule screening. Zebrafish have been shown to exhibit characteristics of addiction to drugs of abuse in non-contingent assays, including conditioned place preference, but contingent assays have been limited to a single assay for alcohol consumption. Using inexpensive electronic, mechanical, and optical components, we developed an automated opioid self-administration assay for zebrafish, enabling us to measure drug seeking and gain insight into the underlying biological pathways. Zebrafish trained in the assay for five days exhibited robust self-administration, which was dependent on the function of the μ-opioid receptor. In addition, a progressive ratio protocol was used to test conditioned animals for motivation. Furthermore, conditioned fish continued to seek the drug despite an adverse consequence and showed signs of stress and anxiety upon withdrawal of the drug. Finally, we validated our assay by confirming that self-administration in zebrafish is dependent on several of the same molecular pathways as in other animal models. Given the ease and throughput of this assay, it will enable identification of important biological pathways regulating drug seeking and could lead to the development of new therapeutic molecules to treat addiction.},
keywords = {},
pubstate = {published},
tppubtype = {article}
}
Chris Wang; Pratyush Gupta; Lucile Fressigne; Gabriel D Bossé; Xin Wang; Martin J Simard; Dave Hansen
TEG-1 CD2BP2 controls miRNA levels by regulating miRISC stability in C. elegans and human cells Journal Article
In: Nucleic Acids Res, vol. 45, no. 3, pp. 1488–1500, 2017, ISSN: 1362-4962.
@article{pmid28180320,
title = {TEG-1 CD2BP2 controls miRNA levels by regulating miRISC stability in C. elegans and human cells},
author = {Chris Wang and Pratyush Gupta and Lucile Fressigne and Gabriel D Bossé and Xin Wang and Martin J Simard and Dave Hansen},
doi = {10.1093/nar/gkw836},
issn = {1362-4962},
year = {2017},
date = {2017-02-01},
journal = {Nucleic Acids Res},
volume = {45},
number = {3},
pages = {1488--1500},
abstract = {MiRNAs post-transcriptionally regulate gene expression by recruiting the miRNA-induced silencing complex (miRISC) to target mRNAs. However, the mechanisms by which miRISC components are maintained at appropriate levels for proper function are largely unknown. Here, we demonstrate that Caenorhabditis elegans TEG-1 regulates the stability of two miRISC effectors, VIG-1 and ALG-1, which in turn affects the abundance of miRNAs in various families. We demonstrate that TEG-1 physically interacts with VIG-1, and complexes with mature let-7 miRNA. Also, loss of teg-1 in vivo phenocopies heterochronic defects observed in let-7 mutants, suggesting the association of TEG-1 with miRISC is necessary for let-7 to function properly during development. Loss of TEG-1 function also affects the abundance and function of other microRNAs, suggesting that TEG-1's role is not specific to let-7. We further demonstrate that the human orthologs of TEG-1, VIG-1 and ALG-1 (CD2BP2, SERBP1/PAI-RBP1 and AGO2) are found in a complex in HeLa cells, and knockdown of CD2BP2 results in reduced miRNA levels; therefore, TEG-1's role in affecting miRNA levels and function is likely conserved. Together, these data demonstrate that TEG-1 CD2BP2 stabilizes miRISC and mature miRNAs, maintaining them at levels necessary to properly regulate target gene expression.},
keywords = {},
pubstate = {published},
tppubtype = {article}
}
Oussama Meziane; Sandra Piquet; Gabriel D Bossé; Dominic Gagné; Eric Paquet; Claude Robert; Michael A Tones; Martin J Simard
The human decapping scavenger enzyme DcpS modulates microRNA turnover Journal Article
In: Sci Rep, vol. 5, pp. 16688, 2015, ISSN: 2045-2322.
@article{pmid26584588,
title = {The human decapping scavenger enzyme DcpS modulates microRNA turnover},
author = {Oussama Meziane and Sandra Piquet and Gabriel D Bossé and Dominic Gagné and Eric Paquet and Claude Robert and Michael A Tones and Martin J Simard},
doi = {10.1038/srep16688},
issn = {2045-2322},
year = {2015},
date = {2015-11-01},
journal = {Sci Rep},
volume = {5},
pages = {16688},
abstract = {The decapping scavenger enzyme DcpS is known for its role in hydrolyzing the cap structure following mRNA degradation. Recently, we discovered a new function in miRNA degradation activation for the ortholog of DcpS in C. elegans. Here we show that human DcpS conserves its role in miRNA turnover. In human cells, DcpS is a nucleocytoplasmic shuttling protein that activates miRNA degradation independently of its scavenger decapping activity in the cytoplasmic compartment. We also demonstrate that this new function for DcpS requires the contribution of the 5'-3' exonuclease Xrn2. Our findings support a conserved role of DcpS as a modulator of miRNA turnover in animals.},
keywords = {},
pubstate = {published},
tppubtype = {article}
}
